0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Gut & Microbiome Human Health Effects Policy & Risk Remediation Sign in to save

mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy

International Journal of Molecular Sciences 2023 30 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 60 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Yuan Gao, Tian Tian

Summary

This review summarizes how the mTOR signaling pathway, a master regulator of cell growth and metabolism, interacts with gut bacteria to influence a wide range of diseases. Disruptions to gut microbiota can trigger mTOR-related problems linked to cancer, diabetes, and inflammatory conditions. While not focused on microplastics directly, this pathway is relevant because microplastic exposure is known to disrupt gut bacteria and may contribute to mTOR-related health issues.

The mammalian or mechanistic target of rapamycin (mTOR) integrates multiple intracellular and extracellular upstream signals involved in the regulation of anabolic and catabolic processes in cells and plays a key regulatory role in cell growth and metabolism. The activation of the mTOR signaling pathway has been reported to be associated with a wide range of human diseases. A growing number of in vivo and in vitro studies have demonstrated that gut microbes and their complex metabolites can regulate host metabolic and immune responses through the mTOR pathway and result in disorders of host physiological functions. In this review, we summarize the regulatory mechanisms of gut microbes and mTOR in different diseases and discuss the crosstalk between gut microbes and their metabolites and mTOR in disorders in the gastrointestinal tract, liver, heart, and other organs. We also discuss the promising application of multiple potential drugs that can adjust the gut microbiota and mTOR signaling pathways. Despite the limited findings between gut microbes and mTOR, elucidating their relationship may provide new clues for the prevention and treatment of various diseases.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Microplastics: An emerging environmental risk factor for gut microbiota dysbiosis and cancer development?

This review examines how microplastics may disrupt the gut microbiome and immune system in ways that could promote cancer development. Evidence from recent studies suggests microplastics can cause chronic inflammation, alter the balance of gut bacteria, and trigger molecular pathways linked to several cancer types including lung, liver, breast, and colon cancer. While more human research is needed, the review highlights a concerning connection between microplastic exposure, gut health, and cancer risk.

Article Tier 2

Microplastics and the gut microbiome: Emerging health concerns and strategies

This review covers how microplastic ingestion affects the gut microbiome, describing mechanisms by which microplastics cause intestinal disorders, disrupt endocrine function, and promote pathogenic bacterial growth, while also noting inhalation and dermal absorption as secondary exposure routes.

Article Tier 2

Impact of micro- and nanoplastics on gastrointestinal diseases: Recent advances

This review summarizes how micro- and nanoplastics can harm the digestive system by causing oxidative stress, inflammation, cell death, and disruption of gut bacteria. These connected pathways can damage the intestinal lining and may contribute to conditions like inflammatory bowel disease and colorectal cancer. The findings highlight the importance of understanding how everyday plastic exposure through food and water could affect gut health over time.

Article Tier 2

mTOR signaling pathway regulation HIF-1 α effects on LPS induced intestinal mucosal epithelial model damage

This paper is not about microplastics; it investigates how the HIF-1α protein modulates intestinal cell damage caused by bacterial lipopolysaccharide (LPS) through the mTOR/P70S6K signaling pathway — a molecular biology study of gut inflammation.

Article Tier 2

Mitigating microplastic-induced organ Damage: Mechanistic insights from the microplastic-macrophage axes

This review is the first comprehensive examination of how microplastics interact with macrophages, the immune cells responsible for engulfing and removing foreign particles from the body. When macrophages absorb microplastics, the resulting oxidative stress disrupts their normal function, leading to inflammation and organ damage, with gut bacteria potentially playing a role in this harmful process.

Share this paper